BIB icon

ProShares Ultra NASDAQ Biotechnology

26 hedge funds and large institutions have $22.9M invested in ProShares Ultra NASDAQ Biotechnology in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.02M
Puts
$3.93M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$6.35M
2
$3.68M
3
$3.21M
4
$1.54M
5
$1.5M
6
$1.41M
7
$1.32M
8
$926K
9
$713K
10
$583K
11
$441K
12
$340K
13
$226K
14
$161K
15
$101K
16
$93K
17
$93K
18
$57K
19
$41K
20
$38K
21
$37K
22
$31K
23
$19K
24
$12K
25
$10.3K